Public Offering

Thumzup Media (TZUP) updated its public offering to include pre-funded warrants for common stock. The funds will target cryptocurrencies, mining equipment, working capital, and general corporate purposes. The offering’s completion is subject to market conditions. Thumzup’s platform pays users for sharing branded content and is developing an AI Lifestyle Agent Marketplace. The announcement contains forward-looking statements subject to risks. Investors should carefully review SEC filings and the prospectus before investing.

Southwest Gas Holdings is reducing its stake in Centuri Holdings through a secondary public offering of 15 million shares at $19.50 each. Underwriters have an option to purchase an additional 2.25 million shares. Carl Icahn’s affiliates will acquire 1,573,500 shares in a concurrent private placement at the same price. J.P. Morgan, Wells Fargo Securities, BofA Securities, and Moelis & Company are lead book-running managers. The offering, expected to close on August 11th, marks Southwest Gas’s strategic realignment and could signal further changes in its Centuri investment.

Prime Medicine (PRME) announced a public offering of 38 million shares at $3.30 per share, expecting $125.4 million in gross proceeds. The Cystic Fibrosis Foundation will purchase 1.8 million shares without underwriter commissions. Underwriters have an option to purchase 5.7 million additional shares. The offering, managed by TD Cowen and BMO Capital Markets, is set to close around August 1, 2025. Proceeds will bolster Prime Medicine’s gene therapy pipeline advancement. The offering may cause dilution for existing shareholders.

SoFi Technologies (NASDAQ: SOFI) has priced its public offering of 71,942,450 shares at $20.85 per share, generating approximately $1.5 billion in gross proceeds. Underwriters have a 30-day option to purchase an additional 10,791,367 shares. The offering is expected to close on July 31, 2025, and SoFi intends to use the proceeds for general corporate purposes, including working capital and strategic opportunities. Goldman Sachs, Citigroup, and Mizuho Securities are acting as underwriters. SoFi offers a suite of digital financial services to over 11.7 million members.

Absci (ABSI) announced the pricing of its public offering of 16,670,000 shares at $3.00 per share, expecting gross proceeds of $50 million. Underwriters have a 30-day option to purchase an additional 2,500,500 shares. Absci will use the funds for program advancements, platform investment, and general corporate purposes. Morgan Stanley, J.P. Morgan, Jefferies, and TD Cowen are managing the offering, expected to close around July 25, 2025.

DEFSEC Technologies Inc. (DFSC) announced the pricing of a CAD$6.8 million public offering consisting of units with common shares (or pre-funded warrants) and warrants. Each unit, priced at CAD$8.955, includes one share/warrant, with warrants exercisable at CAD$10.52 within five years. H.C. Wainwright & Co. is the placement agent. Closing is expected around July 25, 2025. Net proceeds will be used for working capital and general corporate purposes. The offering, while injecting capital, introduces potential dilution for existing shareholders.

Karman Space & Defense (KRMN) announced the pricing of a public offering of 21 million shares at $49 per share, offered by existing stockholders. Underwriters, led by Citigroup and Evercore ISI, have a 30-day option to purchase an additional 3.15 million shares. Karman will not receive any proceeds from the offering, which is expected to close on July 25th, 2025. The SEC approved the registration statement on July 23, 2025. Karman provides critical systems for the space and defense industries.

Tharimmune (THAR) announced a $1.74 million registered direct offering consisting of common stock and warrants. Units are priced at $1.786, including one share or pre-funded warrant and a common warrant. President Street Global is the placement agent. Proceeds will fund working capital and general corporate purposes. The offering is expected to close around July 25, 2025. This funding aims to support Tharimmune’s work in immunology and inflammation therapies, including their clinical asset, TH104.

Civista Bancshares (NASDAQ: CIVB) priced an offering of 3.29 million common shares at $21.25 each, aiming to raise ~$70 million. With an underwriters’ option, proceeds could reach $80.5 million. The capital, expected to close July 14, will fund organic growth and potential acquisitions in Midwest markets. Piper Sandler leads the transaction under Civista’s existing SEC shelf registration.

VERSES AI Inc. (OTCQB: VRSSD) priced a public offering of 1,007,764 units at US$6.946 each, aiming for gross proceeds of approximately $7 million. Each unit includes one Class A subordinate voting share and one-half warrant. Full warrants are exercisable at US$8.409 per share for 36 months. Proceeds will support the company’s balance sheet, research & development initiatives, and operational needs. The offering is led by agents A.G.P. Canada Investments ULC and U.S. affiliate A.G.P./Alliance Global Partners.